PREV logo

PreveCeutical Medical Inc. Stock Price

CNSX:PREV Community·CA$14.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PREV Share Price Performance

CA$0.02
-0.01 (-20.00%)
CA$0.02
-0.01 (-20.00%)
Price CA$0.02

PREV Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

PreveCeutical Medical Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$3.1m

Other Expenses

-CA$3.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.0053
0%
0%
-62.2%
View Full Analysis

About PREV

Founded
n/a
Employees
n/a
CEO
Stephen Van Deventer
WebsiteView website
www.preveceutical.com

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). The company is headquartered in West Vancouver, Canada.

Recent PREV News & Updates

Recent updates

No updates